Literature DB >> 6109134

Intravenous lorazepam to prevent nausea and vomiting associated with cancer chemotherapy.

J Maher.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6109134     DOI: 10.1016/s0140-6736(81)90019-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 2.  Anaesthesia and emesis. II: Prevention and management.

Authors:  M G Palazzo; L Strunin
Journal:  Can Anaesth Soc J       Date:  1984-07

Review 3.  Anaesthetic premedication: aims, assessment and methods.

Authors:  T H Madej; R T Paasuke
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

4.  Antiemetics and cytotoxic drugs.

Authors:  J R Trounce
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-29

5.  Antiemetic prophylaxis with high dose metoclopramide or lorazepam in vomiting induced by chemotherapy.

Authors:  S J Bowcock; A D Stockdale; J A Bolton; A A Kang; S Retsas
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-23

Review 6.  Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds.

Authors:  C Veyrat-Follet; R Farinotti; J L Palmer
Journal:  Drugs       Date:  1997-02       Impact factor: 9.546

Review 7.  Optimum management of nausea and vomiting in cancer chemotherapy.

Authors:  P L Triozzi; J Laszlo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

8.  The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.

Authors:  M E O'Brien; M H Cullen; C Woodroffe; K Kelly; C Burman; K Palmer; N S Stuart; G R Blackledge; J Sharpe
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

9.  Effect of Lorazepam in Reducing Psychological Distress and Anticipatory Nausea and Vomiting in Patients Undergoing Chemotherapy.

Authors:  Aloysius James; Malini Muraleedharan Nair; Dhanya Susan Abraham; Joel Sunny Kovoor; Wesley M Jose; Remya Reghu
Journal:  J Pharmacol Pharmacother       Date:  2017 Jul-Sep
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.